BPC-157 is a research peptide and is not FDA-approved for human use
Originally derived from gastric proteins, BPC-157 works systemically to promote blood flow, tissue repair, and cellular regenerationmaking it highly valuable for patients dealing with injuries, chronic inflammation, gastrointestinal dysfunction, or delayed recovery
Chemical Structures Technical Specifications BPC-157 Component Technical Specifications TB-500 Component The combinations structural diversity BPC-157s compact proline-rich sequence providing gastric acid resistance, paired with TB-500s larger actin-binding domain creates a multi-faceted approach to tissue repair that addresses both localized and systemic healing requirements
Repair & Glow is administered as subcutaneous injections (a small, shallow injection into fatty tissue using an insulin-type needle)
Most topical studies track outcomes over 8-12 week windows, which is where the 6-8 week benchmark for visible changes comes from